K

Laerdal logo

Laerdal

Crunchbase
Pitchbook
Crunchbase

Deals on record

1

Common Fundraising Type

Series B

CorFlow Therapeutics logo
CorFlow Therapeutics

Microvascular Obstruction • Heart attack

Panakes Partners logo
Merieux Equity Partners logo
Laerdal logo
KOFA Healthcare logo

CorFlow Therapeutics AG develops and validates the CoFl system for diagnosing and treating Microvascular Obstruction (MVO) in heart attack patients.

Series B
$48.6M
09/10/2024
Article